Value of Immunomodulator drug(probiotics) in lung function of Bronchial Asthma subjects

Not yet recruiting

Conditions: Moderate persistent asthma,

Registration Number: CTRI/2021/03/032105

Lead Sponsor: Boopathi S

Brief Summary: This study is a randomized parallel group trial to evaluate the role of add on probiotics (lactobacillus fermentum 4 billion cells once daily for 2 months) on impact of lung function and bronchial asthma control that will be conducted in Chettinad Hospital and Research Institute, Kelambakkam,Tamil Nadu, India.The primary outcome is to evaluate the role of add on probiotics on impact of lung function by spirometry and bronchial asthma control.The secondary outcome is to study the impact of probiotics supplementation in risk of asthma exacerbation,allergic rhinitis and its impact on asthma scoring for a period of 2 months.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 84

Inclusion Criteria

All adult stable asthma with or without atopy and allergic rhinitis Both genders.

Exclusion Criteria

Acute Respiratory infection including Tuberculosis Exacerbation Subjects contraindicated and unable to perform spirometry Underlying respiratory disorders.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the role of add on probiotics on impact of lung function by spirometry and bronchial asthma control	Baseline,4 weeks,8 weeks and 12 weeks

Secondary Outcome Measures

Name	Time	Method
To study the impact of probiotics supplementation in risk of asthma exacerbation allergic rhinitis and its impact on asthma scoring	3 months

Trial Locations

Locations (1): Chettinad Hospital and Research centre
🇮🇳
Kancheepuram, TAMIL NADU, India
Chettinad Hospital and Research centre
🇮🇳Kancheepuram, TAMIL NADU, India
Boopathi S
Principal investigator
9444238943
boopathis1993@gmail.com